Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: ZDHHC14

Gene summary for ZDHHC14

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

ZDHHC14

Gene ID

79683

Gene namezinc finger DHHC-type palmitoyltransferase 14
Gene AliasNEW1CP
Cytomap6q25.3
Gene Typeprotein-coding
GO ID

GO:0006464

UniProtAcc

Q8IZN3


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
79683ZDHHC14HTA11_1938_2000001011HumanColorectumAD3.91e-034.73e-01-0.0811
79683ZDHHC14HTA11_347_2000001011HumanColorectumAD1.40e-106.10e-01-0.1954
79683ZDHHC14HTA11_1391_2000001011HumanColorectumAD1.48e-078.21e-01-0.059
79683ZDHHC14HTA11_99999970781_79442HumanColorectumMSS2.42e-04-2.62e-010.294
79683ZDHHC14HTA11_99999965104_69814HumanColorectumMSS1.63e-034.59e-010.281
79683ZDHHC14HTA11_99999974143_84620HumanColorectumMSS1.59e-07-3.32e-010.3005
79683ZDHHC14A015-C-203HumanColorectumFAP4.82e-19-3.88e-01-0.1294
79683ZDHHC14A014-C-040HumanColorectumFAP3.58e-02-4.75e-01-0.1184
79683ZDHHC14A002-C-201HumanColorectumFAP4.06e-04-2.21e-010.0324
79683ZDHHC14A001-C-119HumanColorectumFAP9.96e-03-3.51e-01-0.1557
79683ZDHHC14A001-C-108HumanColorectumFAP3.88e-14-3.88e-01-0.0272
79683ZDHHC14A002-C-205HumanColorectumFAP2.80e-09-3.07e-01-0.1236
79683ZDHHC14A001-C-104HumanColorectumFAP1.51e-04-2.89e-010.0184
79683ZDHHC14A015-C-006HumanColorectumFAP1.49e-04-2.75e-01-0.0994
79683ZDHHC14A015-C-106HumanColorectumFAP4.33e-09-3.26e-01-0.0511
79683ZDHHC14A002-C-114HumanColorectumFAP1.35e-07-3.22e-01-0.1561
79683ZDHHC14A015-C-104HumanColorectumFAP1.04e-18-4.02e-01-0.1899
79683ZDHHC14A001-C-014HumanColorectumFAP7.20e-09-3.38e-010.0135
79683ZDHHC14A002-C-016HumanColorectumFAP9.19e-14-3.03e-010.0521
79683ZDHHC14A015-C-002HumanColorectumFAP1.10e-06-4.46e-01-0.0763
Page: 1 2 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:0090150ColorectumADestablishment of protein localization to membrane100/3918260/187236.01e-116.33e-09100
GO:0006605ColorectumADprotein targeting105/3918314/187231.39e-076.44e-06105
GO:00901502ColorectumMSSestablishment of protein localization to membrane90/3467260/187234.11e-103.49e-0890
GO:00066052ColorectumMSSprotein targeting97/3467314/187236.76e-083.46e-0697
GO:00901504ColorectumFAPestablishment of protein localization to membrane69/2622260/187236.40e-084.54e-0669
GO:00066054ColorectumFAPprotein targeting74/2622314/187233.21e-061.17e-0474
GO:0006612ColorectumFAPprotein targeting to membrane30/2622131/187233.95e-032.75e-0230
GO:00901505ColorectumCRCestablishment of protein localization to membrane51/2078260/187233.59e-059.05e-0451
GO:00066055ColorectumCRCprotein targeting54/2078314/187237.17e-049.28e-0354
Page: 1 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
Page: 1 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
ZDHHC14SNVMissense_Mutationnovelc.866N>Ap.Ser289Tyrp.S289YQ8IZN3protein_codingdeleterious(0)probably_damaging(0.997)TCGA-5L-AAT1-01Breastbreast invasive carcinomaFemale<65III/IVHormone TherapyletrozolSD
ZDHHC14SNVMissense_Mutationc.234N>Gp.Phe78Leup.F78LQ8IZN3protein_codingdeleterious(0.05)possibly_damaging(0.562)TCGA-IR-A3LI-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
ZDHHC14SNVMissense_Mutationc.695N>Gp.Val232Glyp.V232GQ8IZN3protein_codingdeleterious(0)possibly_damaging(0.904)TCGA-AA-3510-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownSD
ZDHHC14SNVMissense_Mutationnovelc.941C>Tp.Ala314Valp.A314VQ8IZN3protein_codingtolerated(1)benign(0.034)TCGA-AA-3950-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
ZDHHC14SNVMissense_Mutationc.734T>Ap.Leu245Hisp.L245HQ8IZN3protein_codingdeleterious(0)probably_damaging(0.95)TCGA-AA-3975-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownSD
ZDHHC14SNVMissense_Mutationrs373622179c.388N>Ap.Asp130Asnp.D130NQ8IZN3protein_codingtolerated(0.24)probably_damaging(0.971)TCGA-AA-3984-01Colorectumcolon adenocarcinomaFemale<65I/IIUnknownUnknownSD
ZDHHC14SNVMissense_Mutationrs537154606c.796G>Ap.Val266Ilep.V266IQ8IZN3protein_codingtolerated(0.23)benign(0.251)TCGA-AM-5821-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
ZDHHC14SNVMissense_Mutationc.1150N>Ap.Leu384Ilep.L384IQ8IZN3protein_codingtolerated(0.78)benign(0)TCGA-F4-6569-01Colorectumcolon adenocarcinomaMale<65I/IIAncillaryleucovorinCR
ZDHHC14deletionFrame_Shift_Delc.430delNp.Tyr146ThrfsTer17p.Y146Tfs*17Q8IZN3protein_codingTCGA-A6-2686-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
ZDHHC14SNVMissense_Mutationnovelc.130N>Tp.Pro44Serp.P44SQ8IZN3protein_codingdeleterious(0.01)probably_damaging(0.916)TCGA-A5-A0G1-01Endometriumuterine corpus endometrioid carcinomaFemale>=65I/IIUnknownUnknownSD
Page: 1 2 3 4 5 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1